We've detected an Ad Blocker in your browser.
Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.
A FREE INTERVENTIONAL EVENT BROADCAST
23 – 25 MARCH 2022
15:00 – 20:00 CET | 10:00 – 15:00 ET
LOG IN
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.
Overview
Radcliffe Cardiology is delighted to announce that Transcatheter Interventions Online (TIO) will return for 2022 on 23 – 25 March, led by the course director, Prof Nicolas van Mieghem from Erasmus MC, Rotterdam, NL.
TIO brings together leading international faculty to create a rich, interactive experience to keep the global interventional cardiology community abreast of the latest developments in transcatheter treatment strategies. Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 will deliver best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Featured Keynote Speaker
Dr Valentin Fuster, Heart and Physician-in-Chief of The Mount Sinai Hospital (New York. US) will be presenting on Clinical Implications of Subclinical Imagenomics.
Join us for three days, each with a distinct educational focus:
- Expert opinion and discussion from international thought-leaders
- Live cases from leading global centres
- Free to view and easy to access
- Symposia and breakouts
- Opportunity to interact with a global audience
- Get your questions answered during live cases and presentations
- 11 hours of CME-accredited learning*
*Transcatheter Interventions Online 2022 has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 11 CME points, equating to 11 hours of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.
Register your interest for 2023
Programme
(Please note this programme is subject to change)
DAY 1: 23 MARCH | 15:00 – 20:00 CET | 10:00 – 15:00 ET
Structural Heart Disease
Presentation and Discussion
15:00 CET- Update On Transcatheter Valve Replacement Technology
- Potential To Predict Device/Host Interactions
- Advanced Structural Heart Planning With 3D Simulation And Printing
- Concomitant Coronary Artery Disease: Shape Up Or Ignore?
- Atrioventricular Valve Disease: Respectable Target Or Innocent Bystander?
- Transcatheter Heart Valve Degeneration – Differences And Similarities With Surgery
Live Cases and Discussion
16:00 CET- Mitral Valve in Valve - Leipzig Heart Centre, DE
- LAA - Rigshospitalet, DK
- TAVI Case - New York-Presbyterian Hospital, US
- TAVI Case - Erasmus MC, Rotterdam, NL
Symposia and Technical Breakout Sessions
17:05 CETOptimising outcomes for the TAVI patient: Key Considerations for First Valve Choice and Implantation Techniques
Chair: Dr Didier Tchétché Supported by an unrestricted educational grant by Medtronic17:05 CET
Current Data and Future Direction in LAAC
Chair: Prof Ole De Backer Supported by Boston Scientific17:05 CET
Key considerations to Ensure Long-Term Patients’ Outcomes
Chair: Prof Dave Smith Supported by AbbottWATCH ON-DEMAND
DAY 2: 24 MARCH | 15:00 – 20:00 CET | 10:00 – 15:00 ET
Coronary Heart Disease: High Risk & Complex PCI
Presentation and Discussion
15:00 CET- Invasive Imaging Appraisal Of Dedicated Calcium Modification Techniques
- Toolbox To Treat Calcified CAD
- Multi Vessel PCI
- Use Of Imaging And Physiology In The Complex PCI Space
- Novel Recanalization Techniques
- Goal Oriented Mindset In CTO Procedures: When To Persist, When To Invest?
Live Cases and Discussion
16:00 CET- Complex with Calcium Modification - Left Main + Calcified Disease - Leipzig Heart Centre, DE
- Complex PCI of a Calcified Lesion – The Mount Sinai Hospital, US
- CTO Case – Erasmus MC, Rotterdam, NL
- CTO Case – New York-Presbyterian Hospital, US
Symposia and Technical Breakout Sessions
17:05 CETGetting it Right First Time in Severe Aortic Stenosis – Key Insights for Long Term Success
Chair: Prof Ole de Backer Supported by an unrestricted educational grant by Boston Scientific17:05 CET
Innovations in Treating Complex PCI: The Role of Orbital Atherectomy
Chair: Prof Nicolas Van Mieghem Supported by CSI17:05 CET
Coronary Physiology in STEMI patients today: Why? When? How?
Chair: Dr Ziad Ali Supported by Opsens MedicalWATCH ON-DEMAND
DAY 3: 25 MARCH | 15:00 – 19:00 CET | 10:00 – 14:00 ET
Debates & Controversies
Presentation and Discussion
15:00 CET- Keynote Presentation by Dr Valentin Fuster - Clinical Implications of Subclinical Imagenomics
- Role Of NOAC In TAVI 2022
Live Cases and Discussion
16:00 CET- TR CASE – Leipzig Heart Centre, DE
- RDN CASE – Erasmus MC, Rotterdam, NL
Debates
18:00 CET- Is Renal Denervation Ready For Prime-Time?
- Do We Need Sex-Specific Trials?
Symposia and Technical Breakout Sessions
17:05 CETSevere Aortic Stenosis: Stratifying Patients for Lifetime Management
Chair: Prof Thomas Modine Supported by an unrestricted educational grant by Edwards Lifescience17:05 CET
The Clinical Evidence for Ultrasound RDN (uRDN) and Building the Therapy Pathway
Chair: Prof Felix Mahfoud Supported by ReCor MedicalWATCH ON-DEMAND
Course Leadership
Prof Nicolas Van Mieghem
COURSE DIRECTOR
Thoraxcenter, Erasmus MC, Rotterdam, NL
Nicolas M. Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, USA and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology in the Thoraxcenter, Erasmus MC as a senior staff member in February 2010.
More info 
Close info
Dr Kendra Grubb
COURSE CO-DIRECTOR
Emory University, Atlanta, US
Kendra Grubb is an experienced Assistant Professor Of Surgery with a demonstrated history of working in the higher education industry. Strong professional skilled in Cardiothoracic Surgery, Clinical Research, Medical Education, Medical Devices, and Medicine.
More info
Close info
Prof David Hildick-Smith
COURSE CO-DIRECTOR
Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK
David Hildick-Smith is a Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and has more than 15 years experience of Interventional Cardiology.
More info
Close info
Dr Ajay Kirtane
COURSE CO-DIRECTOR
Columbia University Medical Center and New York-Presbyterian Hospital, New York, US
Ajay J Kirtane is an Assistant Professor of Clinical Medicine at the Center for Interventional Vascular Therapy, Division of Cardiology, at Columbia University Medical Center (CUMC). He is a practising interventional cardiologist at New York Presbyterian Hospital/CUMC with an interest in coronary and peripheral intervention.
More info
Close info
Dr Roxana Mehran
COURSE CO-DIRECTOR
The Mount Sinai Hospital, New York, US
Roxana Mehran is currently Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures.
More info
Close info
Prof Holger Thiele
COURSE CO-DIRECTOR
Leipzig Heart Center, Leipzig, DE
Holger Thiele is the Medical Director of the Department of Internal Medicine/Cardiology at the Heart Center Leipzig at University of Leipzig which is one of the largest heart centers in Europe. He is full professor of cardiology at the University of Leipzig.
His main research interests are acute myocardial infarction, acute heart failure, cardiogenic shock, mechanical circulatory support, acute cardiovascular care, interventional cardiology and structural heart disease.
Professor Thiele has published over 500 articles in international scientific journals such as the New England Journal of Medicine, The Lancet, JAMA, Circulation, JACC, and the European Heart Journal with a cumulative impact factor of >4500. He has received multiple awards from the German Society of Cardiology and other organisations.
More info
Close info
Faculty
Dr Valentin Fuster
New York, US
Keynote Speaker
Prof Mohamed Abdel-Wahab
Leipzig, DE
Dr Ziad Ali
New York, US
Dr Lluis Asmarats
Barcelona, ES
Dr Christian Besler
Leipzig, DE
Prof Andrew Cook
London, UK
Dr Joost Daemen
Rotterdam, NL
Dr Victoria Delgado
Leiden, NL
Dr Wijnand den Dekker
Rotterdam, NL
Dr Roberto Diletto
Rotterdam, NL
Dr Douglas Fraser
Manchester, UK
Dr Rebecca Hahn
New York, US
Dr Amir Kaki
Detroit, US
Dr Annapoorna Kini
New York, US
Prof Ran Kornowski
Petah Tikva, IL
Dr Azeem Latib
New York, US
Dr Phillip Lurz
Leipzig, DE
Dr Kambis Mashayekhi
Bad Krozingen, DE
Dr Margaret McEntegart
New York, US
Prof Thomas Modine
Lille, FR
Dr Darren Mylotte
Galway, IE
Prof Ole De Backer
Copenhagen, DK
Dr Colum Owens
Belfast, UK
Dr Zsolt Piroth
Budapest, HU
Prof Silvia Schievano
London, UK
Prof Roland Schmeider
Erlangen, DE
Prof Andrew Sharp
Cardiff, UK
Prof Dave Smith
Swansea, UK
Prof Lars Søndergaard
Copenhagen, DK
Prof Mark Spence
Belfast UK
Dr Dmitry Sulimov
Leipzig, DE
Dr Didier Tchétché
Toulouse, FR
Dr David Wood
Vancouver, CA
WATCH ON-DEMAND
Feedback from TIO 2021
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
Learning Objectives
Following the activities, participants will be able to:
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
Educational Partners:
Supporting Partners:
Media Partner
If you’re interested in becoming an educational partner at TIO, please contact sales@radcliffe-group.com
Official Journal
Interventional Cardiology: Reviews, Research, Resources (ICR³) is an international, English language, peer-reviewed journal that publishes articles continuously on ICRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in interventional cardiology.
Led by Editor-in-Chief Peter O'Kane, along with Deputy Editors and an editorial board of world-renowned physicians, the journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.
Download the latest copy of ICR3
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
- We build on the best science
- We work hands-on with our community
- We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.